1Kirkland, JB (2009) Niacin status, NAD distribution and ADP-ribose metabolism. Curr Pharm Des 15, 3–11.
2Institute of Medicine (1998) Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline, pp. 123–149. Washington, DC: National Academy Press.
3Renwick, AG (2006) Toxicology of micronutrients: adverse effects and uncertainty. J Nutr 136, 493S–501S.
4Zhou, SS, Li, D, Zhou, YM, et al. (2010) B-vitamin consumption and the prevalence of diabetes and obesity among the US adults: population based ecological study. BMC Public Health 10, 746.
5Li, D, Sun, WP, Zhou, YM, et al. (2010) Chronic niacin overload may be involved in the increased prevalence of obesity in US children. World J Gastroenterol 16, 2378–2387.
6Zhou, SS, Zhou, YM, Li, D, et al. (2013) Early infant exposure to excess multivitamin: a risk factor for autism? Autism Res Treat 2013, 963697.
7United States Congress (1980) Infant Formula Act of 1980, in Public Law, pp. 96–359. Washington, DC: United States Capitol Health Documents Room.
8Arenz, S, Rückerl, R, Koletzko, B, et al. (2004) Breast-feeding and childhood obesity – a systematic review. Int J Obes Relat Metab Disord 28, 1247–1256.
9Harder, T, Bergmann, R, Kallischnigg, G, et al. (2005) Duration of breastfeeding and risk of overweight: a meta-analysis. Am J Epidemiol 162, 397–403.
10Greenbaum, CJ, Kahn, SE & Palmer, JP (1996) Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM. Diabetes 45, 1631–1634.
11Robertson, KD (2005) DNA methylation and human disease. Nat Rev Genet 6, 597–610.
12Drong, AW, Lindgren, CM & McCarthy, MI (2012) The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92, 707–715.
13Zhou, SS, Zhou, YM, Li, D, et al. (2011) Dietary methyl-consuming compounds and metabolic syndrome. Hypertens Res 34, 1239–1245.
14Mrochek, JE, Jolley, RL, Young, DS, et al. (1976) Metabolic response of humans to ingestion of nicotinic acid and nicotinamide. Clin Chem 22, 1821–1827.
15Sun, WP, Li, D, Lun, YZ, et al. (2012) Excess nicotinamide inhibits methylation-mediated degradation of catecholamines in normotensives and hypertensives. Hypertens Res 35, 180–185.
16Ramsahoye, BH (2002) Measurement of genome wide DNA methylation by reversed-phase high-performance liquid chromatography. Methods 27, 156–161.
17Blount, BC & Ames, BN (1994) Analysis of uracil in DNA by gas chromatography–mass spectrometry. Anal Biochem 219, 195–200.
18Valavanidis, A, Vlachogianni, T & Fiotakis, C (2009) 8-Hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27, 120–139.
19Borrás, C, Gómez-Cabrera, MC & Viña, J (2011) The dual role of p53: DNA protection and antioxidant. Free Radic Res 45, 643–652.
20Shibata, K, Shimada, H & Taguchi, H (1996) Fate of nicotinamide differs due to an intake of nicotinamide. Biosci Biotechnol Biochem 60, 1204–1206.
21Shibata, K (1991) Effects of dietary pyrazinamide on the growth of weanling rats fed with a nicotinic acid-free and tryptophan-limited diet. Agric Biol Chem 55, 3111–3112.
22Chaput, JP & Tremblay, A (2009) The glucostatic theory of appetite control and the risk of obesity and diabetes. Int J Obes (Lond) 33, 46–53.
23Winter, SL & Boyer, JL (1973) Hepatic toxicity from large doses of vitamin B3 (nicotinamide). N Engl J Med 289, 1180–1182.
24Handler, P & Dann, WJ (1942) The inhibition of rat growth by nicotinamide. J Biol Chem 146, 357–368.
25Butte, NF, Wong, WW, Ferlic, L, et al. (1990) Energy expenditure and deposition of breast-fed and formula-fed infants during early infancy. Pediatr Res 28, 631–640.
26Wells, JC & Davies, PS (1995) Diet and behavioural activity in 12-week-old infants. Ann Hum Biol 22, 207–215.
27Butte, NF, Smith, EO & Garza, C (1991) Heart rates of breast-fed and formula-fed infants. J Pediatr Gastroenterol Nutr 13, 391–396.
28Ueland, PM (2011) Choline and betaine in health and disease. J Inherit Metab Dis 34, 3–15.
29Otani, H (2011) Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15, 1911–1926.
30James, AM, Collins, Y, Logan, A, et al. (2012) Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 23, 429–434.
31Konstantinova, SV, Tell, GS, Vollset, SE, et al. (2008) Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 138, 914–920.
33Zhou, SS, Li, D, Sun, WP, et al. (2009) Nicotinamide overload may play a role in the development of type 2 diabetes. World J Gastroenterol 15, 5674–5684.